136 related articles for article (PubMed ID: 8403532)
1. Proliferative effect of mevalonate metabolites other than isoprenoids on cultured vascular smooth muscle cells.
Sawamura M; Li N; Nara Y; Yamori Y
Clin Exp Pharmacol Physiol; 1993; 20(7-8):509-14. PubMed ID: 8403532
[TBL] [Abstract][Full Text] [Related]
2. Effect of lovastatin and fluoromevalonate on phosphatidylinositol 3-kinase activity stimulated with PDGF.
Iwama A; Sawamura M; Nara Y; Yamori Y
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S318-20. PubMed ID: 9072409
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.
Cuthbert JA; Lipsky PE
J Biol Chem; 1990 Oct; 265(30):18568-75. PubMed ID: 2211719
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates.
Cuthbert JA; Lipsky PE
J Biol Chem; 1991 Sep; 266(27):17966-71. PubMed ID: 1917936
[TBL] [Abstract][Full Text] [Related]
5. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.
Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R
Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498
[TBL] [Abstract][Full Text] [Related]
6. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1995 Apr; 55(8):1732-40. PubMed ID: 7712482
[TBL] [Abstract][Full Text] [Related]
8. Mevalonate availability and cardiovascular functions.
Roullet JB; Xue H; Pappu AS; Roullet C; Holcomb S; McCarron DA
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11728-32. PubMed ID: 8265617
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].
Corsini A; Arnaboldi L; Quarato P; Ferri N; Granata A; Fumagalli R; Paoletti R
C R Seances Soc Biol Fil; 1997; 191(2):169-94. PubMed ID: 9255346
[TBL] [Abstract][Full Text] [Related]
11. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
12. Mevalonate deprivation impairs IGF-I/insulin signaling in human vascular smooth muscle cells.
Martínez-González J; Viñals M; Vidal F; Llorente-Cortés V; Badimon L
Atherosclerosis; 1997 Dec; 135(2):213-23. PubMed ID: 9430371
[TBL] [Abstract][Full Text] [Related]
13. Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.
Sawamura M; Nara Y; Yamori Y
J Biol Chem; 1992 Mar; 267(9):6051-5. PubMed ID: 1556116
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis.
Munro E; Patel M; Chan P; Betteridge L; Clunn G; Gallagher K; Hughes A; Schachter M; Wolfe J; Sever P
Eur J Clin Invest; 1994 Nov; 24(11):766-72. PubMed ID: 7890015
[TBL] [Abstract][Full Text] [Related]
16. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
17. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats.
Rosen B; Barg J; Zimlichman R
Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1243-51. PubMed ID: 10619588
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
Raiteri M; Arnaboldi L; McGeady P; Gelb MH; Verri D; Tagliabue C; Quarato P; Ferraboschi P; Santaniello E; Paoletti R; Fumagalli R; Corsini A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1144-53. PubMed ID: 9190847
[TBL] [Abstract][Full Text] [Related]
19. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation.
Nishimura M; Tanaka T; Yasuda T; Kurakata S; Kitagawa M; Yamada K; Saito Y; Hirai A
Kidney Int Suppl; 1999 Jul; 71():S97-100. PubMed ID: 10412748
[TBL] [Abstract][Full Text] [Related]
20. The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells.
Choi KH; Kang SW; Lee SW; Lee HY; Han DS; Kang BS
Yonsei Med J; 1995 Jul; 36(3):251-61. PubMed ID: 7660676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
